Session: Controversies in the Financing and Delivery of Antiretroviral Drugs for AIDS in Africa

3274.0: Monday, November 8, 2004: 2:30 PM-4:00 PM

Oral

Controversies in the Financing and Delivery of Antiretroviral Drugs for AIDS in Africa

This session will focus on programmatic issues that arise when antiretroviral treatment is made available at a large scale in the resource-poor countries of Africa.

Learning Objectives: On completion of the session, participants will be able to: 1) list and describe at least five key issues that arise in resource-poor health systems when efforts are made to scale-up ARV treatment for AIDS; 2) describe the trade-offs in the use of NGOs versus government health systems as the primary providers of HAART; 3) discuss the advantages and disadvantages of siting the ARV services in primary care versus specialty clinics; and 4) explain the risks to the primary care health system that arise when ARV scale-up is undertaken without adequate preparation and rational resource allocation.

Moderator(s):

Mary Anne Mercer, MPH, DrPH

2:30 PM

Introductory Remarks

2:35 PM

ARV Scaleup: A Threat to the Health System
Josh Ruxin, PhD

2:50 PM

Does HAART Have a Role in Primary Care?
Paula E. Brentlinger, MD, MPH

3:05 PM

Key elements for scaling up ARV treatment based on MSF's field experience